Balance Sheet Data

AgeX Therapeutics, Inc. (AGE)

$0.64

+0.01 (+0.96%)

Year
A/P
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Projected
2024
Projected
2025
Projected
2026
Projected
2027
Projected
Total Cash 6.712.350.530.580.640.130.090.060.040.02
Total Cash (%)
Account Receivables 0.130.360.330.02000000
Account Receivables (%)
Inventories ----------
Inventories (%)
Accounts Payable 1.161.321.660.120.030.020.010.010.010
Accounts Payable (%)
Capital Expenditure -1.89-0.64-1.61-0.12-0.03-0.02-0.01-0.01-0.01-0
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.